These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 9696366)

  • 21. Chemical meningitis related to intra-CSF liposomal cytarabine.
    Durand B; Zairi F; Boulanger T; Bonneterre J; Mortier L; Le Rhun E
    CNS Oncol; 2017 Oct; 6(4):261-267. PubMed ID: 29057672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Leptomeningeal metastases: a review of evaluation and treatment.
    Chamberlain MC
    J Neurooncol; 1998 May; 37(3):271-84. PubMed ID: 9524085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Leptomeningeal metastasis.
    Chamberlain MC
    Semin Neurol; 2010 Jul; 30(3):236-44. PubMed ID: 20577930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current diagnosis and treatment of leptomeningeal metastasis.
    DeAngelis LM
    J Neurooncol; 1998; 38(2-3):245-52. PubMed ID: 9696379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Central nervous system relapse of systemic non-Hodgkin's lymphoma: results of treatment based on high-dose methotrexate combination chemotherapy.
    Bokstein F; Lossos A; Lossos IS; Siegal T
    Leuk Lymphoma; 2002 Mar; 43(3):587-93. PubMed ID: 12002763
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Leukemic and lymphomatous meningitis: incidence, prognosis and treatment.
    Chamberlain MC; Nolan C; Abrey LE
    J Neurooncol; 2005 Oct; 75(1):71-83. PubMed ID: 16215818
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical improvement and survival in breast cancer leptomeningeal metastasis correlate with the cytologic response to intrathecal chemotherapy.
    Clatot F; Philippin-Lauridant G; Ouvrier MJ; Nakry T; Laberge-Le-Couteulx S; Guillemet C; Veyret C; Blot E
    J Neurooncol; 2009 Dec; 95(3):421-426. PubMed ID: 19557501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Results of compassionate therapy with intrathecal depot liposomal cytarabine in acute myeloid leukemia meningeosis.
    Sancho JM; Deben G; Parker A; Piñana JL; Bolam S; Sánchez-García E; Giménez E; Pascual T; Fernández-Abellán P; Palomera L; Ribera JM
    Int J Hematol; 2007 Jul; 86(1):33-6. PubMed ID: 17675264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Salvage intracerebrospinal fluid thiotepa in breast cancer-related leptomeningeal metastases: a retrospective case series.
    Le Rhun E; Taillibert S; Devos P; Zairi F; Turpin A; Rodrigues I; Cazin JL; Pierret MF; André C; Dubois F; Bonneterre J; Chamberlain MC
    Anticancer Drugs; 2013 Nov; 24(10):1093-7. PubMed ID: 23962903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toxicity of treatment for neoplastic meningitis.
    Siegal T
    Curr Oncol Rep; 2003 Jan; 5(1):41-9. PubMed ID: 12493149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intrathecal chemotherapy.
    Kerr JZ; Berg S; Blaney SM
    Crit Rev Oncol Hematol; 2001 Mar; 37(3):227-36. PubMed ID: 11248578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neoplastic meningitis from breast cancer: feasibility and activity of long-term intrathecal liposomal Ara-C combined with dose-dense temozolomide.
    Hoffmann AL; Buhk JH; Strik H
    Anticancer Res; 2009 Dec; 29(12):5191-5. PubMed ID: 20044635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prophylaxis and treatment of leptomeningeal carcinomatosis in solid tumors of adulthood.
    Hildebrand J
    J Neurooncol; 1998; 38(2-3):193-8. PubMed ID: 9696371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New strategies in the management of leptomeningeal metastases.
    Groves MD
    Arch Neurol; 2010 Mar; 67(3):305-12. PubMed ID: 20212228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relevance of intraventricular chemotherapy for leptomeningeal metastasis in breast cancer: a randomised study.
    Boogerd W; van den Bent MJ; Koehler PJ; Heimans JJ; van der Sande JJ; Aaronson NK; Hart AA; Benraadt J; Vecht ChJ
    Eur J Cancer; 2004 Dec; 40(18):2726-33. PubMed ID: 15571954
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leptomeningeal metastasis.
    Chamberlain MC
    Curr Opin Neurol; 2009 Dec; 22(6):665-74. PubMed ID: 19738466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical outcome and efficacy of current anti-leukemic therapy for leptomeningeal involvement in acute myeloid leukemia.
    Kwon JH; Koh YI; Yoon SS; Park S; Kim I
    Int J Hematol; 2016 Nov; 104(5):574-581. PubMed ID: 27431487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical trial of intrathecal administration of 5-fluoro-2'-deoxyuridine for treatment of meningeal dissemination of malignant tumors.
    Nakagawa H; Yamada M; Maeda N; Iwatsuki K; Hirayama A; Ikenaka K
    J Neurooncol; 1999; 45(2):175-83. PubMed ID: 10778733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current treatment approaches for neoplastic meningitis: nursing management of patients receiving intrathecal DepoCyt.
    Craig C
    Oncol Nurs Forum; 2000 Sep; 27(8):1225-30; quiz 1231-2. PubMed ID: 11013903
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sanctuary site leptomeningeal metastases in HER-2 positive breast cancer: A review in the era of trastuzumab.
    Kordbacheh T; Law WY; Smith IE
    Breast; 2016 Apr; 26():54-8. PubMed ID: 27017242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.